Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125692431 | 12569243 | 1 | I | 20160714 | 20160719 | 20160719 | EXP | PHHY2016VE098119 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160719 | CN | VE | VE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125692431 | 12569243 | 1 | SS | LEPONEX | CLOZAPINE | 1 | Oral | 300 MG, QD | 0 | 300 | MG | QD | |||||||
125692431 | 12569243 | 2 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 200 MG, QD | 16608 | 200 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125692431 | 12569243 | 1 | Schizophrenia |
125692431 | 12569243 | 2 | Epilepsy |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125692431 | 12569243 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125692431 | 12569243 | Abnormal behaviour | |
125692431 | 12569243 | Aggression | |
125692431 | 12569243 | Dizziness | |
125692431 | 12569243 | Insomnia | |
125692431 | 12569243 | Malaise | |
125692431 | 12569243 | Mood altered | |
125692431 | 12569243 | Restlessness | |
125692431 | 12569243 | Schizophrenia | |
125692431 | 12569243 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |